<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Alexpandi</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>De Mesquita</surname>
    <given-names>J. F.</given-names>
   </name>
   <name>
    <surname>Pandian</surname>
    <given-names>S. K.</given-names>
   </name>
   <name>
    <surname>Ravi</surname>
    <given-names>A. V.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: an in silico analysis</article-title>. 
  <source>Front. Microbiol.</source>
  <volume>11</volume>. 
  <pub-id pub-id-type="doi">10.3389/fmicb.2020.01796</pub-id>
 </mixed-citation>
</ref>
